| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/20/2001 | WO2001014538A3 Plants with modified polyunsaturated fatty acids |
| 09/20/2001 | WO2001014424A3 Human ctla-4 antibodies and their uses |
| 09/20/2001 | WO2001013944A3 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 09/20/2001 | WO2001013715A3 Animal model and uses thereof |
| 09/20/2001 | WO2001012660A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 09/20/2001 | WO2001011078A8 Amplification method for detection of target nucleic acids involving fluorescence energy transfer |
| 09/20/2001 | WO2001009306A9 Mutant bacterial strains l-lysine production |
| 09/20/2001 | WO2001008702A9 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment |
| 09/20/2001 | WO2001007065B1 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 09/20/2001 | WO2001005971A3 Secreted polypeptides and corresponding polynucleotides |
| 09/20/2001 | WO2001002540A9 Adenoviral vectors for treating disease |
| 09/20/2001 | WO2001000820A3 METHODS AND COMPOSITIONS FOR PRODUCING 5' ENRICHED cDNA LIBRARIES |
| 09/20/2001 | WO2000075335A3 Bacteriophage rm 378 of a thermophilic host organism |
| 09/20/2001 | WO2000046246A8 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
| 09/20/2001 | WO2000044774A9 Inhibition of stat3 signal transduction for human cancer therapy |
| 09/20/2001 | WO2000040757A9 Method of identifying nucleic acids |
| 09/20/2001 | WO2000037491A3 Dnas encoding proteins with signal sequences |
| 09/20/2001 | WO2000037490A3 Outer surface proteins, their genes, and their use |
| 09/20/2001 | WO2000034436A3 Facs assisted methods for introducing individual chromosomes into cells |
| 09/20/2001 | WO2000024867A3 Plant histidine biosynthetic enzymes |
| 09/20/2001 | WO2000018899A3 Angiotensin converting enzyme homolog and its use |
| 09/20/2001 | WO1999040102A9 Novel molecules of the card-related protein family and uses thereof |
| 09/20/2001 | US20010023501 Methods for making male-sterile plants |
| 09/20/2001 | US20010023500 Leukotriene B4 receptor transgenic mice |
| 09/20/2001 | US20010023349 Hypodermic needle with weeping tip and method of use |
| 09/20/2001 | US20010023290 Process for separation of polynucleotide fragments |
| 09/20/2001 | US20010023242 Polypeptide from snake venom |
| 09/20/2001 | US20010023069 Method for making insulin precursors and insulin precursor analogs |
| 09/20/2001 | US20010023068 Novel compounds |
| 09/20/2001 | US20010023062 Screening receptors |
| 09/20/2001 | US20010023061 Assaying the effect of test tumor cell modulation |
| 09/20/2001 | US20010022977 Administering apoptosis agent |
| 09/20/2001 | US20010022971 IBD-associated microbial nucleic acid molecules |
| 09/20/2001 | US20010022969 Sepsis therapy |
| 09/20/2001 | EP1144615A3 METHODS AND COMPOSITIONS FOR PRODUCING 5' ENRICHED cDNA LIBRARIES |
| 09/20/2001 | EP1144608A3 Synthetic vectors, transgenic plants containing them, and methods for obtaining them |
| 09/20/2001 | EP1144589A3 Plant histidine biosynthetic enzymes |
| 09/20/2001 | DE10013618A1 New polypeptides from Drosophila melanogaster have biological activity of peptide receptor, useful to find new compounds for plant protection and insecticides |
| 09/20/2001 | DE10013580A1 Rezeptor für Latrotoxin aus Insekten Receptor for Latrotoxin from insects |
| 09/20/2001 | DE10012283A1 Controlling gene expression in gram positive organisms using a phosphate controllable promoter and a phosphate regulation system is useful to express heterologous proteins in gram positive bacteria |
| 09/20/2001 | DE10012220A1 Test system comprising cells expressing different cytochrome P450 2D6 alleles used to investigate genetically caused metabolite toxicity and to determine toxic, mutagenic or carcinogenic effect of compounds |
| 09/20/2001 | DE10011358A1 Producing a modified L-form bacterial strain by culturing the strain in complex medium and subjecting it to temperature stress, provides bacteria useful to produce recombinant proteins |
| 09/20/2001 | DE10010959A1 Transferring material through cell membranes, useful e.g. in genetic engineering or hydride production, using aqueous solution containing trehalose, increases cell survival |
| 09/20/2001 | DE10010342A1 Method for reducing the endotoxin content of nucleic acid (I) is derived from natural, genetic engineering or biotechnological sources is used to produce high-purity plasmid DNA from natural sources |
| 09/20/2001 | CA2539214A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2534391A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2534186A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2534030A1 Screted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2534018A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2533991A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2533903A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2533831A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2531917A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2406672A1 Atm mutations in breast cancer |
| 09/20/2001 | CA2403405A1 Hcv ns2/3 fragments and uses thereof |
| 09/20/2001 | CA2403397A1 Methods and compositions for rna interference |
| 09/20/2001 | CA2403393A1 Methods and compositions for immunoregulation |
| 09/20/2001 | CA2403344A1 Effective nuclear reprogramming in mammals |
| 09/20/2001 | CA2403222A1 Mitochondrial dosimeter |
| 09/20/2001 | CA2403205A1 Compositions and methods of regulated protein expression in gut endocrine k cells |
| 09/20/2001 | CA2403201A1 Family of mechanically sensitive human potassium channels activated by polyunsaturated fatty acids and use thereof |
| 09/20/2001 | CA2403196A1 Method and composition for treating airway hyperresponsiveness |
| 09/20/2001 | CA2403189A1 Inflammation-inducible hybrid promoters, vectors containing same and uses thereof |
| 09/20/2001 | CA2403113A1 Methods of improving homologous recombination |
| 09/20/2001 | CA2403084A1 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia" |
| 09/20/2001 | CA2403000A1 Embryonic stem cells and neural progenitor cells derived therefrom |
| 09/20/2001 | CA2402940A1 G-protein coupled receptors |
| 09/20/2001 | CA2402936A1 Human phospholipases and polynucleotides encoding the same |
| 09/20/2001 | CA2402912A1 Transgenic mice containing targeted gene disruptions |
| 09/20/2001 | CA2402877A1 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same |
| 09/20/2001 | CA2402866A1 Novel subtilase enzymes having an improved wash performance on egg stains |
| 09/20/2001 | CA2402855A1 Transcription transactivator protein |
| 09/20/2001 | CA2402772A1 Apolipoprotein-a-i regulation of t-cell signalling |
| 09/20/2001 | CA2402729A1 Human immune response proteins |
| 09/20/2001 | CA2402721A1 Derivatives of breast cancer antigen her-2 for therapeutical use |
| 09/20/2001 | CA2402718A1 Fish vaccine against piscirickettsia salmonis |
| 09/20/2001 | CA2402614A1 Insulin homolog polypeptide zins4 |
| 09/20/2001 | CA2402562A1 A process for the production of human interferon alpha from genetically engineered yeast |
| 09/20/2001 | CA2402530A1 Blocking leukocyte emigration and inflammation by interfering with cd99 |
| 09/20/2001 | CA2402483A1 Methods for detection of differences in nucleic acids |
| 09/20/2001 | CA2402424A1 Methods of making and using microarrays of anti-ligands for the analysis of protein expression in cells |
| 09/20/2001 | CA2402319A1 Oligonucleotide analogues, methods of synthesis and methods of use |
| 09/20/2001 | CA2402294A1 Immunomodulatory formulations and methods for use thereof |
| 09/20/2001 | CA2402259A1 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections |
| 09/20/2001 | CA2402250A1 Immunomodulatory polynucleotide sequences for use in suppressing hepatitis virus infection |
| 09/20/2001 | CA2402248A1 Polypeptides and nucleic acids encoding same |
| 09/20/2001 | CA2402245A1 Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same |
| 09/20/2001 | CA2402237A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine |
| 09/20/2001 | CA2402227A1 Human g-coupled protein receptor kinases and polynucleotides encoding the same |
| 09/20/2001 | CA2402189A1 Methods and apparatus for the location and concentration of polar analytes using an alternating electric field |
| 09/20/2001 | CA2402147A1 Melanin concentrating hormone receptor chimeric and fusion proteins |
| 09/20/2001 | CA2402086A1 Self antigen vaccines for treating b cell lymphomas and other cancers |
| 09/20/2001 | CA2402041A1 Antisense oligonucleotides of the human chk1 gene and uses thereof |
| 09/20/2001 | CA2402014A1 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections |
| 09/20/2001 | CA2401743A1 Hypoallergenic transgenic soybeans |
| 09/20/2001 | CA2401448A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2401417A1 High fidelity reverse transcriptases and uses thereof |
| 09/20/2001 | CA2401406A1 Human olfactory receptors and genes encoding same |
| 09/20/2001 | CA2401273A1 Il-17 receptor like molecules and uses thereof |
| 09/20/2001 | CA2401270A1 Method for labeling individual cells |